Mylan Pharmaceuticals Inc. et al. vs. UCB Pharma GmbH
Explore the PTAB proceeding IPR2016-00517 filed by Mylan Pharmaceuticals Inc. et al. on 2016-01-28. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2016-00517
Filing Date
2016-01-28
Accorded Filing Date
2016-01-28
Institution Decision Date
2016-07-20
Last Modified Date
2022-10-10
Proceeding Type
IPR
Termination Date
2017-07-19
Trial Status
Final Written Decision
Parties & Counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Represented By
Stockwell, Mitchellet alPatent Owner / Respondent
UCB Pharma GmbH
Represented By
Oelke, Jeffreyet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Final Written Decision
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 25825 | George Badenoch | +1 212-908-6185 |
| 40074 | Tyler Maddry | +1 202-955-1964 |
| 40131 | Gregory Porter | +1 713-220-4621 |
| 40479 | Gary Abelev | +1 212-850-2881 |
| 41993 | William Merone | +1 202-220-4270 |
| 44487 | Yisun Song | +1 202-955-1966 |
| 54863 | Daniel Shanley | +1 202-220-4420 |
| 59436 | Andrew Kasnevich | +1 202-662-2770 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 7,985,772 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 8,338,478 B2 | US Continuation / Sibling | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 98,108,608 A | European Counterpart (EP) | View Official Patent → |
| 🇪🇺 European Patent Office (UPC States) | EP 957,073 A1 | European Counterpart (EP) | View Official Patent → |
| 🇺🇸 United States | US 6,713,464 B1 | US Continuation / Sibling | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 1999058478 A1 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 7,230,030 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 7,384,980 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 7,855,230 B2 | US Continuation / Sibling | View Official Patent → |
Mylan Pharmaceuticals Inc. et al. v. UCB Pharma GmbH
Mylan Pharmaceuticals Inc. et al. v. UCB Pharma GmbH
Mylan Pharmaceuticals Inc. et al. v. UCB Pharma GmbH
Pfizer Inc. v. Dr. Reddy's Laboratories Ltd.
Pfizer Inc. v. Accord Healthcare Inc.USA
Pfizer Inc. v. Zydus Pharmaceuticals (USA)Inc.
Pfizer Inc. v. Amerigen Pharmaceuticals Inc.